Revocation of advice to avoid Terumo hypodermic needles

The Dutch Health Care Inspectorate (IGZ) revokes its advice to temporarily avoid the use of two types of hypodermic needles manufactured by the company Terumo. This decision was taken on april 17th after investigation by the Dutch National Institute for Public Health and the Environment (RIVM). In less than 1% of the investigated needles - both of Terumo as of other manufacturers - glue was found, in very small amounts.

Three weeks ago IGZ received detailed information of possible problems with two types of hypodermic needles, manufactured by the company Terumo. It was alleged that these needles bear traces of glue which could become detached and could pose a risk to patient safety. IGZ has opened an investigation together with RIVM to determine whether there is any foundation to this claim and the extent of the resultant risk.

Pending the results of the investigation, IGZ has advised the use of alternative hypodermic needles, if available, rather than those supplied by Terumo. RIVM has so far examined over 5000 needles. In this investigation, both glue and plastic particles were found in the needles of multiple manufacturers. Within two weeks RIVM will determine whether the use of these needles pose health risks, primarily focusing on the possible effects of the glue.

Based on the results of the first phase of the investigation, there is no reason at this time to avoid using the two types of Terumo Needles.